List of SBIR/STTR awards granted to PAI Life Sciences
PAI Life SciencesName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to PAI Life Sciences in March, 2019 for $224,988.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI140708-01A1 | Phase I | 224,988 | March 1, 2019 | |||||||
A SBIR Phase I contract was awarded to PAI Life Sciences in November, 2018 for $224,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI142908-01 | Phase I | 224,999 | November 20, 2018 | |||||||
A SBIR Phase II contract was awarded to PAI Life Sciences in March, 2020 for $706,627.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI103983-06A1 | Phase II | 706,627 | March 13, 2020 | |||||||
A SBIR Phase II contract was awarded to PAI Life Sciences in June, 2020 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI140708-02 | Phase II | 1,000,000 | June 23, 2020 | |||||||
A SBIR Phase I contract was awarded to PAI Life Sciences in September, 2021 for $243,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43IP001164-01 | Phase I | 243,000 | September 30, 2021 | |||||||
A SBIR Phase II contract was awarded to PAI Life Sciences in September, 2019 for $720,945.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA206607-02A1 | Phase II | 720,945 | September 19, 2019 | |||||||
A SBIR Phase I contract was awarded to PAI Life Sciences for $299,184.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93019C00008 | Phase I | 299,184 | ||||||||
A SBIR Phase II contract was awarded to PAI Life Sciences for $2,961,685.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93019C00028 | Phase II | 2,961,685 | ||||||||
A SBIR Phase I contract was awarded to PAI Life Sciences for $597,953.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93022C00004 | Phase I | 597,953 | ||||||||
A SBIR Phase I contract was awarded to PAI Life Sciences in March, 2017 for $224,998.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI127053-01A1 | Phase I | 224,998 | March 15, 2017 | |||||||
A SBIR Phase I contract was awarded to PAI Life Sciences in March, 2016 for $208,639.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL131195-01 | Phase I | 208,639 | March 1, 2016 | |||||||
A SBIR Phase I contract was awarded to PAI Life Sciences in September, 2016 for $199,997.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA206607-01A1 | Phase I | 199,997 | September 20, 2016 | |||||||
A SBIR Phase I contract was awarded to PAI Life Sciences in July, 2014 for $600,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI109936-01 | Phase I | 600,000 | July 1, 2014 | |||||||
A STTR Phase I contract was awarded to PAI Life Sciences in August, 2017 for $157,401.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI134271-01 | Phase I | 157,401 | August 1, 2017 | |||||||
A SBIR Phase II contract was awarded to PAI Life Sciences in January, 2016 for $3,828,539.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI103983-03A1 | Phase II | 3,828,539 | January 1, 2016 | |||||||
A SBIR Phase I contract was awarded to PAI Life Sciences for $444,428.0 USD from the U.S. Department of Health & Human Services. | SBIR | 272201600036C-0-0-0 | Phase I | 444,428 | ||||||||
A SBIR Phase II contract was awarded to PAI Life Sciences for $719,796.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI066613-02 | Phase II | 719,796 | ||||||||
A SBIR Phase I contract was awarded to PAI Life Sciences for $600,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI103983-01 | Phase I | 600,000 | ||||||||
A SBIR Phase II contract was awarded to PAI Life Sciences for $1,645,906.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA162582-02 | Phase II | 1,645,906 | ||||||||
A SBIR Phase II contract was awarded to PAI Life Sciences for $1,486,937.0 USD from the U.S. Department of Health & Human Services. | SBIR | 272201500030C-0-0-0 | Phase II | 1,486,937 | ||||||||
A SBIR Phase I contract was awarded to PAI Life Sciences for $191,159.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA183379-01 | Phase I | 191,159 | ||||||||
A SBIR Phase I contract was awarded to PAI Life Sciences for $441,905.0 USD from the U.S. Department of Health & Human Services. | SBIR | 272201600037C-0-0-0 | Phase I | 441,905 | ||||||||
A SBIR Phase I contract was awarded to PAI Life Sciences for $210,507.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43AI130014 | Phase I | 210,507 | ||||||||
A SBIR Phase I contract was awarded to PAI Life Sciences for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI066613-01A1 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to PAI Life Sciences for $153,580.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI082800-01 | Phase I | 153,580 |
